You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201471 - 201480 of 205043 results
  1. Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer

    SBC: TROPHOGEN INC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Thyroid cancer is increasingly prevalent and the most common malignancy of endocrine tissues, and most patients require lifelong surveillance with diagnostic thyroid-stimulating hormone (TSH)-stimulated radioiodine uptake as well as thyroid remnant or tumor ablation with radioiodine therapy. Other imaging techniques including ultrasound and positron-emission to ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Technologies to Improve Software Acquisition/Development Process

    SBC: Analytical Services, Inc.            Topic: MDA04034

    The Missile Defense Agency (MDA) does not currently have an automated, centralized database to store Rad-Hardening (Rad-Hard) vendor data and corresponding test results. Portions of this data are currently stored in a spreadsheet, without consistency, distributed access, robust data search, filtering, or reporting capabilities. These data are not readily available to the developers of mission-crit ...

    SBIR Phase II 2006 Department of DefenseMissile Defense Agency
  3. Target Engagement Biomarkers for Alzheimer's Therapeutics

    SBC: COGNITION THERAPEUTICS, INC.            Topic: NIA

    AbstractProject Summary Cognition Therapeutics IncCogRxhas discovered CTa novel oligomer receptor antagonist that is the only drug candidate demonstrated to prevent and displace binding of Abeta oligomers to receptors on brain cellsBy stopping the initiating event in the Abeta oligomer cascadethis first in class drug candidate completely blocks downstream synaptotoxicity and restores memory to nor ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Developing a new DFU dressing

    SBC: Noveratech L.L.C.            Topic: 200

    ABSTRACTDiabetic foot ulcers (DFUs) are the leading cause of nontraumatic lower extremity amputations in the United States and are responsible for more hospitalizations than any other complication of diabetes. Despite thousands of dressings developed in the past century, none have shown any specific effectiveness as DFU treatments. Currently, even the best available treatments achieve only a 50% h ...

    SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  5. Acquiring Probabilistic Knowledge for Information Fusion

    SBC: DECISIVE ANALYTICS CORPORATION            Topic: AF06065

    Acquiring probabilistic knowledge for the development of fusion models can prove to be a difficult task. In many applications, the lack of availability of historical data forces the modelers to rely extensively on expert judgment techniques which traditionally requires a large amount of manpower and is exceedingly time-consuming. Under Phase I of this effort, the DAC Team has proven the feasibilit ...

    SBIR Phase II 2007 Department of DefenseAir Force
  6. Rapid Assessment of Illicit Drugs in Wastewater

    SBC: GINER INC            Topic: NIDA

    PROJECT SUMMARY/ABSTRACT Opioid crisis (abuse and misuse) is an epidemic of global concern to public health and safety, causing over 70,000 deaths annually in the United States. Obtaining real-time data on the use of opioids is a major challenge as this information is limited to population surveys and drug surveillance data. There is an urgent public health need for monitoring tools to achieve cru ...

    SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  7. Biometrics-at-a-distance

    SBC: VAWD APPLIED SCIENCE & TECHNOLOGY CORP            Topic: SB121004

    Sensors capable of remotely detecting and measuring human vital signs and other physiological activity at a stand-off range greater than 10 meters within a building or behind an obstruction (i.e. non-line-of-sight) in a cluttered environment is of significant interest to the DOD, law enforcement, search and rescue, and the intelligence communities.The capability to remotely monitor vital signs als ...

    SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency
  8. Run-time Verification and Validation for Safety-Critical Flight Control Systems

    SBC: BARRON ASSOCIATES, INC.            Topic: AF04246

    As the complexity of flight controllers grows, so does the cost associated with verification and validation (V&V). Current-generation controllers are already reaching a level of complexity that pushes the envelopes of existing V&V approaches, with little hope for affordable V&V of next-generation intelligent systems. One possible solution is to combine run-time monitors for subsystem components ...

    SBIR Phase II 2005 Department of DefenseAir Force
  9. Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis

    SBC: OASIS PHARMACEUTICALS, LLC            Topic: NIDDK

    DESCRIPTION provided by applicant Non alcoholic steatohepatitis NASH is characterized by fatty changes in the liver with inflammation and hepatocellular injury that in advanced stages leads to fibrosis and cirrhosis and high mortality rates NASH is frequently associated with other common metabolic abnormalities such as insulin resistance and visceral obesity Liver transplantation is curren ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Reactive Nanocomposite Materials for Enhanced Lethality Kinetic Warheads

    SBC: REACTIVE METALS INTERNATIONAL, INC.            Topic: MDA15004

    This effort is aimed to increase lethality of kinetic energy warheads by developing metal-based materials with densities in the range of 1-10g/cm3, burning with temperatures in excess of 4000K, generating chemical energy reaching 2kcal/g, while releasing the energy with 10-500us upon impact initiation. Approved for Public Release | 16-MDA-8951 (15 December 16)

    SBIR Phase II 2017 Department of DefenseMissile Defense Agency
US Flag An Official Website of the United States Government